<!DOCTYPE html>
  <!--[if IEMobile 7]><html class="no-js ie iem7 not-responsive" lang="en" dir="ltr"><![endif]-->
  <!--[if lte IE 6]><html class="no-js ie lt-ie9 lt-ie8 lt-ie7 not-responsive" lang="en" dir="ltr"><![endif]-->
  <!--[if (IE 7)&(!IEMobile)]><html class="no-js ie lt-ie9 lt-ie8 not-responsive" lang="en" dir="ltr"><![endif]-->
  <!--[if IE 8]><html class="no-js ie lt-ie9 not-responsive" lang="en" dir="ltr"><![endif]-->
  <!--[if (gte IE 9)|(gt IEMobile 7)]><html class="no-js ie responsive" lang="en" dir="ltr" prefix=": og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book# profile: http://ogp.me/ns/profile# video: http://ogp.me/ns/video# product: http://ogp.me/ns/product# content: http://purl.org/rss/1.0/modules/content/ dc: http://purl.org/dc/terms/ foaf: http://xmlns.com/foaf/0.1/ rdfs: http://www.w3.org/2000/01/rdf-schema# sioc: http://rdfs.org/sioc/ns# sioct: http://rdfs.org/sioc/types# skos: http://www.w3.org/2004/02/skos/core# xsd: http://www.w3.org/2001/XMLSchema#"><![endif]-->
  <!--[if !IE]><!--><html class="no-js responsive" lang="en" dir="ltr" prefix=": og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book# profile: http://ogp.me/ns/profile# video: http://ogp.me/ns/video# product: http://ogp.me/ns/product# content: http://purl.org/rss/1.0/modules/content/ dc: http://purl.org/dc/terms/ foaf: http://xmlns.com/foaf/0.1/ rdfs: http://www.w3.org/2000/01/rdf-schema# sioc: http://rdfs.org/sioc/ns# sioct: http://rdfs.org/sioc/types# skos: http://www.w3.org/2004/02/skos/core# xsd: http://www.w3.org/2001/XMLSchema#"><!--<![endif]-->
<head>
  <title>Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa | OPA | Department of Justice</title>
  <!--[if IE]><![endif]-->
<meta charset="utf-8" />
<meta http-equiv="cleartype" content="on" />
<meta name="MobileOptimized" content="width" />
<link rel="shortcut icon" href="https://www.justice.gov/sites/default/files/favicon.png" type="image/png" />
<link rel="profile" href="http://www.w3.org/1999/xhtml/vocab" />
<link rel="apple-touch-icon-precomposed" href="https://www.justice.gov/sites/all/themes/justice/apple-touch-icon-precomposed-144x144.png" sizes="144x144" />
<link rel="apple-touch-icon-precomposed" href="https://www.justice.gov/sites/all/themes/justice/apple-touch-icon-precomposed.png" />
<script async="async" id="_fed_an_ua_tag" src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=DOJ&amp;sp=find&amp;yt=true&amp;subagency=opa"></script>
<link rel="apple-touch-icon-precomposed" href="https://www.justice.gov/sites/all/themes/justice/apple-touch-icon-precomposed-114x114.png" sizes="114x114" />
<meta name="HandheldFriendly" content="true" />
<link rel="apple-touch-icon-precomposed" href="https://www.justice.gov/sites/all/themes/justice/apple-touch-icon-precomposed-72x72.png" sizes="72x72" />
<meta name="viewport" content="width=device-width" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa" />
<meta property="og:title" content="Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa" />
<meta property="og:description" content="American pharmaceutical giant Eli Lilly and Company today agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and Drug Administration (FDA). This resolution includes a criminal fine of $515 million, the largest ever in a health care case, and the largest criminal fine for an individual corporation ever imposed in a United States criminal prosecution of any kind. Eli Lilly will also pay up to $800 million in a civil settlement with the federal government and the states." />
<meta property="og:image" content="https://www.justice.gov/sites/all/modules/features/doj_sharing/images/doj-seal-fb.jpg" />
<meta name="twitter:title" content="Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa" />
<meta name="twitter:description" content="American pharmaceutical giant Eli Lilly and Company today agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and Drug Administration (FDA). This resolution includes a criminal fine of $515 million, the largest ever in a health care case, and the largest criminal fine for an individual corporation ever imposed in a United States criminal prosecution of any kind. Eli Lilly will also pay up to $800 million in a civil settlement with the federal government and the states." />
<meta name="twitter:image" content="https://www.justice.gov/sites/all/modules/features/doj_sharing/images/doj-seal-fb.jpg" />
  <link type="text/css" rel="stylesheet" href="https://www.justice.gov/sites/default/files/advagg_css/css__L9xBrWyh760kB07M33QP0YVvVMX64sk2-1FFDY8mDi4__048dHB8FVClU_xvw_jwAwb_WpKr0NqcM6EMUvrjSZNI__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.css" media="all" />

<!--[if lte IE 8]>
<link type="text/css" rel="stylesheet" href="https://www.justice.gov/sites/default/files/advagg_css/css__JQfwsVb8AHjJsxvkLORr8MKWY6kpVUNsHSIlUeHBziE__c440f7m3jDBbATa_fuiq9g0Wr5MNT4XqPpzO4WPT32Y__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.css" media="all" />
<![endif]-->
</head>
<body x-ms-format-detection="none" class="html not-front not-logged-in page-node page-node- page-node-33916 node-type-press-release og-context og-context-node og-context-node-1664 i18n-en section-opa og-context-office-of-public-affairs one-sidebar sidebar-second">
  <a id="skip-link" href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
    <div class="l-page not-panelized not-panelized">
  <a name="page-top"></a>
  <div class="l-header-wrapper">
    <header class="l-header" role="banner">
      <div class="l-branding site-branding">
                  <a href="/" title="The United States Department of Justice" rel="home" class="site-branding__logo desktop"><img src="https://www.justice.gov/sites/default/files/logo.png" alt="The United States Department of Justice" /></a>
          <a href="/" title="The United States Department of Justice" rel="home" class="site-branding__logo mobile"><img src="https://www.justice.gov/sites/default/files/mobile-logo.png" alt="The United States Department of Justice" /></a>
        
              </div>

        <div class="l-region l-region--header">
    <div id="block-block-3" class="block block--block block--block-3">
        <h2 class="block__title block__title">En Espanol</h2>
      <div class="block__content block__content">
    <p><a style="display:block;" href="http://www.justice.gov/espanol">en Espaol</a></p>
  </div>
</div>
<div id="block-follow-site" class="block block--follow block--follow-site">
        <h2 class="block__title block__title">Stay Connected with Justice:</h2>
      <div class="block__content block__content">
    <div class='follow-links clearfix site'><span class='follow-link-wrapper follow-link-wrapper-twitter'><a href="http://www.twitter.com/TheJusticeDept" class="follow-link follow-link-twitter follow-link-site" title="Follow us on Twitter">Twitter</a>
</span><span class='follow-link-wrapper follow-link-wrapper-instagram'><a href="https://instagram.com/thejusticedept" class="follow-link follow-link-instagram follow-link-site" title="Follow us on Instagram">Instagram</a>
</span><span class='follow-link-wrapper follow-link-wrapper-facebook'><a href="http://www.facebook.com/DOJ" class="follow-link follow-link-facebook follow-link-site" title="Follow us on Facebook">Facebook</a>
</span><span class='follow-link-wrapper follow-link-wrapper-youtube'><a href="http://www.youtube.com/TheJusticeDepartment" class="follow-link follow-link-youtube follow-link-site" title="Follow us on YouTube">YouTube</a>
</span><span class='follow-link-wrapper follow-link-wrapper-this-site'><a href="/doj/news-feeds" class="follow-link follow-link-this-site follow-link-site" title="Follow us on RSS">RSS</a>
</span><span class='follow-link-wrapper follow-link-wrapper-newsletter'><a href="https://public.govdelivery.com/accounts/USDOJ/subscriber/new" class="follow-link follow-link-newsletter follow-link-site" title="Follow us on Email">Email</a>
</span></div>  </div>
</div>
<div id="block-usasearch-hosted-form" class="block block--usasearch-hosted block--usasearch-hosted-form">
        <div class="block__content block__content">
    <form class="usasearch-hosted-box" action="https://search.justice.gov/search" method="get" id="usasearch-hosted-box" accept-charset="UTF-8"><div><div class="container-inline">
      <h2 class="element-invisible">Search form</h2>
    <div class="form-item form-type-textfield form-item-usasearch-hosted-box">
  <label class="element-invisible" for="edit-usasearch-hosted-box--2">Search </label>
 <input class="usagov-search-autocomplete ui-autocomplete-input ui-corner-all form-text" autocomplete="off" type="text" name="query" placeholder="Search this site" id="edit-usasearch-hosted-box--2" value="" size="15" maxlength="128" />
</div>
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="affiliate" value="justice" />
</div>
</div></form>  </div>
</div>
<div id="block-nice-menus-1" class="block block--nice-menus block--nice-menus-1">
        <h2 class="block__title block__title"><span class="nice-menu-hide-title">Main menu</span></h2>
      <div class="block__content block__content">
    <ul class="nice-menu nice-menu-down nice-menu-main-menu" id="nice-menu-1"><li class="menu-1258 menu-path-front first odd "><a href="/" title="">Home</a></li>
<li class="menu-1259 menuparent  menu-path-node-82626  even "><a href="/about" title="">About</a><ul><li class="menu-9686 menu-path-node-1652 first odd "><a href="/ag" title="">The Attorney General</a></li>
<li class="menu-1267 menu-path-node-82606  even "><a href="/doj/budget-and-performance" title="">Budget &amp; Performance</a></li>
<li class="menu-51706 menu-path-node-632231  odd "><a href="/about/history" title="">History</a></li>
<li class="menu-89781 menu-path-node-1666  even last"><a href="/opcl" title="">Privacy Program</a></li>
</ul></li>
<li class="menu-1260 menuparent  menu-path-node-33666-chart  odd "><a href="/agencies/chart" title="">Agencies</a><ul><li class="menu-90596 menu-path-node-33666-chart first odd "><a href="/agencies/chart" title="">Organizational Chart</a></li>
<li class="menu-90591 menu-path-node-924706  even last"><a href="/agencies/alphabetical-listing-components-programs-initiatives" title="">Alphabetical Listing</a></li>
</ul></li>
<li class="menu-1262 menuparent  menu-path-node-82271  even "><a href="/resources" title="">Resources</a><ul><li class="menu-92026 menu-path-node-82476 first odd "><a href="/grants" title="">Grants</a></li>
<li class="menu-1261 menu-path-node-82486  even "><a href="/business" title="">Business</a></li>
<li class="menu-1272 menu-path-justicegov-forms  odd "><a href="http://www.justice.gov/forms" title="">Forms</a></li>
<li class="menu-1273 menu-path-node-643761  even "><a href="/publications" title="">Publications</a></li>
<li class="menu-5306 menu-path-largecases  odd last"><a href="/largecases" title="">Information for Victims in Large Cases</a></li>
</ul></li>
<li class="menu-1263 menuparent  menu-path-node-24871 active-trail  odd "><a href="/briefing-room" title="">News</a><ul><li class="menu-1276 menu-path-node-780336 active-trail first odd "><a href="/news" title="" class="active">Press Releases</a></li>
<li class="menu-1278 menu-path-node-890381  even "><a href="/public-schedule" title="">Public Schedule</a></li>
<li class="menu-1279 menu-path-node-665661  odd "><a href="/videos" title="">Videos</a></li>
<li class="menu-1280 menu-path-opa-galleries  even last"><a href="/opa/galleries" title="">Photos</a></li>
</ul></li>
<li class="menu-92596 menuparent  menu-path-node-865991  even "><a href="/careers" title="">Careers</a><ul><li class="menu-2925 menu-path-node-3643 first odd "><a href="/legal-careers">Legal Careers</a></li>
<li class="menu-3650 menu-path-node-796646  even "><a href="/careers/veteran-recruitment" title="">Veteran Recruitment</a></li>
<li class="menu-92601 menu-path-node-6001  odd last"><a href="/careers/disability-hiring" title="">Disability Hiring</a></li>
</ul></li>
<li class="menu-1265 menu-path-node-82636  odd last"><a href="/contact-us" title="">Contact</a></li>
</ul>
  </div>
</div>
  </div>
          </header>
  </div>

  <div class="l-lower">
    
    <div class="l-main-wrapper">
      <div class="l-main">
        <div class="site-info">
          <h2 class="element-invisible">You are here</h2><div class="breadcrumb"><a href="/">Home</a> &raquo; <a href="/opa">Office of Public Affairs</a> &raquo; <a href="/opa/pr">News</a></div>        </div>

                  <div class="pre-content clearfix">
              <div class="l-region l-region--pre-content">
    <div id="block-doj-sharing-doj-sharing" class="block block--doj-sharing block--doj-sharing-doj-sharing">
        <div class="block__content block__content">
    <div class="doj-sharing" style="display:none;">
  <a id="doj-sharing-toggle" tabindex="0" title="Choose a social sharing platform">
    Share  </a>
  <ul>
    <li>
      <a href="http://www.facebook.com/sharer/sharer.php?u=https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa" target="_blank" title="Share on Facebook" data-event-label="Share on Facebook">Facebook</a>
    </li>
    <li>
      <a href="http://twitter.com/intent/tweet?url=https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa&amp;text=Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa" target="_blank" title="Share on Twitter" data-event-label="Share on Twitter">Twitter</a>
    </li>
    <li>
      <a href="https://plus.google.com/share?url=https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa" target="_blank" title="Share on Google+" data-event-label="Share on Google+">Google+</a>
    </li>
    <li>
      <a href="http://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa&amp;title=Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa" target="_blank" title="Share on LinkedIn" data-event-label="Share on LinkedIn">LinkedIn</a>
    </li>
    <li>
      <a href="http://digg.com/submit?url=https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa&amp;title=Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa" target="_blank" title="Share on Digg" data-event-label="Share on Digg">Digg</a>
    </li>
    <li>
      <a href="http://reddit.com/submit?url=https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa&amp;title=Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa" target="_blank" title="Share on Reddit" data-event-label="Share on Reddit">Reddit</a>
    </li>
    <li>
      <a href="http://www.stumbleupon.com/submit?url=https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa&amp;title=Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa" target="_blank" title="Share on StumbleUpon" data-event-label="Share on StumbleUpon">StumbleUpon</a>
    </li>
    <li>
      <a href="http://pinterest.com/pin/create/button/?url=https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa&amp;media=https://www.justice.gov/sites/all/modules/features/doj_sharing/images/doj-seal-pin.png&amp;title=Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa" target="_blank" title="Share on Pinterest" data-event-label="Share on Pinterest">Pinterest</a>
    </li>
    <li>
      <a href="mailto:?to=&body=https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa&subject=Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa" title="Email" data-event-label="Email">Email</a>
    </li>
  </ul>
</div>
  </div>
</div>
  </div>
          </div>
        
        
        <div class="l-content" role="main">
                    <a id="main-content" tabindex="-1"></a>
                                <h1>Justice News</h1>
                    
          
                                        

<article about="/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa" typeof="sioc:Item foaf:Document" role="article" class="node node--press-release node--full node--press-release--full">
      <header>
                  <span property="dc:title" content="Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa" class="rdf-meta element-hidden"></span>    </header>
  
  
  <div class="node__content">
    
          <div class="pr-header">
        <div class="department">Department of Justice</div>
        <div class="agency">Office of Public Affairs</div>
      </div>
      <hr>
      <div class="pr-info">
        <div class="urgency-state">FOR IMMEDIATE RELEASE</div>
        <div class="field field--name-field-pr-date field--type-datetime field--label-hidden"><div class="field__items"><div class="field__item even"><span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2009-01-15T00:00:00-05:00">Thursday, January 15, 2009</span></div></div></div>      </div>
      <h1 id="node-title">Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa</h1>
              <h2 id="node-subtitle" class="center"><div class="field field--name-field-pr-subtitle field--type-text field--label-hidden"><div class="field__items"><div class="field__item even">$515 Million Criminal Fine Is Largest Individual Corporate Criminal Fine in History; Civil Settlement up to $800 Million</div></div></div></h2>
              <div class="field field--name-field-pr-body field--type-text-long field--label-hidden"><div class="field__items"><div class="field__item even"><p>American pharmaceutical giant Eli Lilly and Company today agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and Drug Administration (FDA), the Department of Justice announced today. This resolution includes a criminal fine of $515 million, the largest ever in a health care case, and the largest criminal fine for an individual corporation ever imposed in a United States criminal prosecution of any kind. Eli Lilly will also pay up to $800 million in a civil settlement with the federal government and the states.</p>

<p>Eli Lilly agreed to enter a global resolution with the United States to resolve criminal and civil allegations that it promoted its antipsychotic drug Zyprexa for uses not approved by the FDA, the Department said. Such unapproved uses are also known as "off-label" uses because they are not included in the drugs FDA approved product label.</p>

<p>Assistant Attorney General for the Civil Division Gregory G. Katsas and acting U.S. Attorney for the Eastern District of Pennsylvania Laurie Magid today announced the filing of a criminal information against Eli Lilly for promoting Zyprexa for uses not approved by the FDA. Eli Lilly, headquartered in Indianapolis, is charged in the information with promoting Zyprexa for such off-label or unapproved uses as treatment for dementia, including Alzheimers dementia, in elderly people.</p>

<p>The company has signed a plea agreement admitting its guilt to a misdemeanor criminal charge. Eli Lilly also signed a civil settlement to resolve civil claims that by marketing Zyprexa for unapproved uses, it caused false claims for payment to be submitted to federal insurance programs such as Medicaid, TRICARE and the Federal Employee Health Benefits Program, none of which provided coverage for such off-label uses.</p>

<p>The plea agreement provides that Eli Lilly will pay a criminal fine of $515 million and forfeit assets of $100 million. The civil settlement agreement provides that Eli Lilly will pay up to an additional $800 million to the federal government and the states to resolve civil allegations originally brought in four separate lawsuits under the <em>qui tam </em>provisions of the federal False Claims Act. The federal share of the civil settlement amount is $438 million. Under the terms of the civil settlement, Eli Lilly will pay up to $361 million to those states that opt to participate in the agreement.</p>

<p>Under the Food, Drug, and Cosmetic Act (FDCA), a company must specify the intended uses of a product in its new drug application to the FDA. Before approving a drug, the FDA must determine that the drug is safe and effective for the use proposed by the company. Once approved, the drug may not be marketed or promoted for off-label uses.</p>

<p>The FDA originally approved Zyprexa, also known by the chemical name olanzapine, in Sept. 1996 for the treatment of manifestations of psychotic disorders. In March 2000, FDA approved Zyprexa for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. In Nov. 2000, FDA approved Zyprexa for the short term treatment of schizophrenia in place of the management of the manifestations of psychotic disorders. Also in Nov. 2000, FDA approved Zyprexa for maintaining treatment response in schizophrenic patients who had been stable for approximately eight weeks and were then followed for a period of up to eight months. Zyprexa has never been approved for the treatment of dementia or Alzheimers dementia.</p>

<p>The criminal information, filed in the Eastern District of Pennsylvania, alleges that from Sept. 1999 through at least Nov. 2003, Eli Lilly promoted Zyprexa for the treatment of agitation, aggression, hostility, dementia, Alzheimers dementia, depression and generalized sleep disorder. The information alleges that Eli Lillys management created marketing materials promoting Zyprexa for off-label uses, trained its sales force to disregard the law and directed its sales personnel to promote Zyprexa for off-label uses.</p>

<p>The information alleges that beginning in 1999, Eli Lilly expended significant resources to promote Zyprexa in nursing homes and assisted-living facilities, primarily through its long-term care sales force. Eli Lilly sought to convince doctors to prescribe Zyprexa to treat patients with disorders such as dementia, Alzheimers dementia, depression, anxiety, and sleep problems, and behavioral symptoms such as agitation, aggression, and hostility.</p>

<p>The information further alleges that the FDA never approved Zyprexa for the treatment of dementia, Alzheimer's dementia, psychosis associated with Alzheimer's disease, or the cognitive deficits associated with dementia.</p>

<p>The information also alleges that building on its unlawful promotion and success in the long-term care market, Eli Lilly executives decided to market Zyprexa to primary-care physicians. In Oct. 2000, Eli Lilly began this off-label marketing campaign targeting primary care physicians, even though the company knew that there was virtually no approved use for Zyprexa in the primary-care market. Eli Lilly trained its primary-care physician sales representatives to promote Zyprexa by focusing on symptoms, rather than Zyprexas FDA approved indications.</p>

<p>The <em>qui tam </em>lawsuits alleged that between Sept. 1999 and the end of 2005, Eli Lilly promoted Zyprexa for use in patients of all ages and for the treatment of anxiety, irritability, depression, nausea, Alzheimers and other mood disorders. The <em>qui tam </em>lawsuits also alleged that the company funded continuing medical education programs, through millions of dollars in grants, to promote off-label uses of its drugs, in violation of the FDAs requirements.</p>

<p>"Off-label promotion of pharmaceutical drugs is a serious crime because it undermines the FDAs role in protecting the American public by determining that a drug is safe and effective for a particular use before it is marketed," said Gregory G. Katsas, Assistant Attorney General for the Civil Division. "This settlement demonstrates the Departments ongoing diligence in prosecuting cases involving violations of the Food, Drug, and Cosmetic Act, and recovering taxpayer dollars used to pay for drugs sold as a result of off-label marketing campaigns."</p>

<p>"When pharmaceutical companies ignore the governments process for protecting the public, they undermine the integrity of the doctor-patient relationship and place innocent people in harms way," said acting U.S. Attorney for the Eastern District of Pennsylvania, Laurie Magid. "Off-label marketing created unnecessary risks for patients. People have an absolute right to their doctors medical expertise, and to know that their health care providers judgment has not be clouded by misinformation from a company trying to build its bottom line."</p>

<p>The global resolution includes the following agreements:</p>

<ul><li>A plea agreement signed by Eli Lilly admitting guilt to the criminal charge of misbranding. Specifically, Eli Lilly admits that between Sept. 1999 and March 31, 2001, the company promoted Zyprexa in elderly populations as treatment for dementia, including Alzheimers dementia. Eli Lilly has agreed to pay a $515 million criminal fine and to forfeit an additional $100 million in assets.</li>
	<li>A civil settlement between Eli Lilly, the United States and various States, in which Eli Lilly will pay up to $800 million to the federal government and the states to resolve False Claims Act claims and related state claims by Medicaid and other federal programs and agencies including TRICARE, the Federal Employees Health Benefits Program, Department of Veterans Affairs, Bureau of Prisons and the Public Health Service Entities. The federal government will receive $438,171,544 from the civil settlement. The state Medicaid programs and the District of Columbia will share up to $361,828,456 of the civil settlement, depending on the number of states that participate in the settlement.</li>
	<li>The <em>qui tam </em>relators will receive $78,870,877 from the federal share of the settlement amount.</li>
	<li>A Corporate Integrity Agreement (CIA) between Eli Lilly and the Office of Inspector General of the Department of Health and Human Services. The five-year CIA requires, among other things, that a Board of Directors committee annually review the companys compliance program and certify its effectiveness; that certain managers annually certify that their departments or functional areas are compliant; that Eli Lilly send doctors a letter notifying them about the global settlement; and that the company post on its website information about payments to doctors, such as honoraria, travel or lodging. Eli Lilly is subject to exclusion from Federal health care programs, including Medicare and Medicaid, for a material breach of the CIA and subject to monetary penalties for less significant breaches.</li>
</ul><p>"OIGs Corporate Integrity Agreement will increase the transparency of Eli Lillys interactions with physicians and strengthen Eli Lillys accountability for its compliance with the law," said Department of Health and Human Services Inspector General Daniel R. Levinson. "This historic resolution demonstrates the Governments commitment to improvethe integrity of drug promotion activities."</p>

<p>In addition to the $1.415 billion criminal and civil settlement announced today, Eli Lilly previously agreed to pay $62 million to settle consumer protection lawsuits brought by 33 states. The state consumer protection settlements were announced on Oct. 7, 2008.</p>

<p>"Today's announcement of the filing of a criminal charge and the unprecedented terms of this settlement demonstrates the government's increasing efforts aimed at pharmaceutical companies that choose to put profits ahead of the public's health," said Special Agent-in-Charge Kim Rice of FDA's Office of Criminal Investigations. "The FDA will continue to devote resources to criminal investigations targeting pharmaceutical companies that disregard the safeguards of the drug approval process and recklessly promote drugs for uses for which they have not been proven to be safe and effective."</p>

<p>"The illegal scheme used by Eli Lilly significantly impacted the integrity of TRICARE, the Department of Defense's healthcare system," said Ed Bradley, Special Agent-in-Charge, Defense Criminal Investigative Service. "This illegal activity increases patients costs, threatens their safety and negatively affects the delivery of healthcare services to the over nine million military members, retirees and their families who rely on this system. Todays charges and settlement demonstrate the ongoing commitment of the Defense Criminal Investigative Service and its partners in law enforcement to investigate and prosecute those that abuse the government's healthcare programs at the expense of the taxpayers and patients."</p>

<p>"This case should serve as still another warning to all those who break the law in order to improve their profits," said Patrick Doyle, Special Agent-in-Charge of the Office of Inspector General for the Department of Health and Human Services in Philadelphia. "OIG, working with our law enforcement partners, will pursue and bring to justice those who would steal from vulnerable beneficiaries and the taxpayers."</p>

<p>The civil settlement resolves four <em>qui tam</em> actions filed in the Eastern District of Pennsylvania: <em>United States ex rel. Rudolf, et al., v. Eli Lilly and Company,</em> Civil Action No. 03-943 (E.D. Pa.)<em>; United States ex rel. Faltaous v. Eli Lilly and Company,</em> Civil Action No. 06-2909 (E.D. Pa.)<em>; United States ex rel. Woodward v. Dr. George B. Jerusalem, et al.,</em> Civil Action No. 06-5526 (E.D. Pa.)<em>; </em>and<em> United States ex rel. Vicente v. Eli Lilly and Company, </em>Civil Action No. 07-1791 (E.D. Pa.). All of those cases were filed by former Eli Lilly sales representatives.</p>

<p>The criminal case is being prosecuted by the U.S. Attorneys Office for the Eastern District of Pennsylvania and the Office of Consumer Litigation of the Justice Departments Civil Division. The civil settlement was reached by the U.S. Attorneys Office and the Commercial Litigation Branch of the Justice Departments Civil Division.</p>

<p>This matter was investigated by the FDAs Office of Criminal Investigations, the Defense Criminal Investigative Service and the Department of Health and Human Services Office of Inspector General.</p>

<p>Assistance was provided by representatives of FDAs Office of Chief Counsel and the National Association of Medicaid Fraud Control Units.</p>

<p>The Corporate Integrity Agreement was negotiated by the Office of Inspector General of the Department of Health and Human Services.</p>

<p>Eli Lilly's guilty plea and sentence is not final until accepted by the U.S. District Court.</p>
</div></div></div>    <div class="pr-fields">
      <div class="field field--name-field-pr-topic field--type-taxonomy-term-reference field--label-above"><div class="field__label">Topic(s):&nbsp;</div><div class="field__items"><div class="field__item even">Consumer Protection</div></div></div><div class="field field--name-field-pr-component field--type-taxonomy-term-reference field--label-above"><div class="field__label">Component(s):&nbsp;</div><div class="field__items"><div class="field__item even"><a href="http://www.justice.gov/civil/" typeof="skos:Concept" property="rdfs:label skos:prefLabel" datatype="">Civil Division</a></div></div></div><div class="field field--name-field-pr-number field--type-text field--label-above"><div class="field__label">Press Release Number:&nbsp;</div><div class="field__items"><div class="field__item even">09-038</div></div></div>    </div>
  </div>

      <div class="node__updated">Updated October 22, 2014</div>
</article>
                  </div>

          <aside class="l-region l-region--sidebar-second">
    <div id="block-views-og-sidebar-block-sitewide" class="block block--views block--views-og-sidebar-block-sitewide">
        <div class="block__content block__content">
    <div class="view view-og-sidebar view-id-og_sidebar view-display-id-block_sitewide view-dom-id-53a91d63d62f78b4a094d2c5fa2278ee views-display-type-block views-display-type-block">
        
  
  
      <div class="view-content">
        <div class="views-row views-row-1 views-row-odd views-row-first views-row-last">
    <div class="panelizer-view-mode node node-full node-sidebar node-753">
        <div class="astraea panel-astraea panel-display--astraea">
  <div class="panels-region-wrapper astraea-region astraea-region--content">
    <div class="panel-pane pane-fieldable-panels-pane pane-uuid-8c0cfd94-19c6-4ca7-b15d-960ce1fd79be pane-bundle-quick-links panels-pane-style-gold-double">
  <div class="panel-pane-inner">
                        <div class="fieldable-panels-pane" class="fieldable-panels-pane">
    <div class="field field--name-field-ql-image field--type-image field--label-hidden"><div class="field__items"><div class="field__item even"><img typeof="foaf:Image" src="https://www.justice.gov/sites/default/files/images/quick_links/action-center_0.jpg" width="227" height="108" /></div></div></div>
<div class="field field--name-field-ql-links field--type-link-field field--label-hidden">
    <div class="field__items">
    <div class="first-half">
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/report-crime">Report a Crime</a>        </div>
              <div class="field__item odd">
          <a href="https://www.justice.gov/careers">Get a Job</a>        </div>
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/locate-prison-inmate-or-sex-offender">Locate a Prison, Inmate, or Sex Offender</a>        </div>
              <div class="field__item odd">
          <a href="https://www.justice.gov/grants">Apply for a Grant</a>        </div>
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/submit-complaint">Submit a Complaint</a>        </div>
              <div class="field__item odd">
          <a href="https://oig.justice.gov/hotline/">Report Waste, Fraud, Abuse or Misconduct to the Inspector General</a>        </div>
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/find-sales-seized-property">Find Sales of Seized Property</a>        </div>
          </div>
    <div class="second-half">
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/find-help-and-information-crime-victims">Find Help and Information for Crime Victims</a>        </div>
              <div class="field__item odd">
          <a href="https://www.justice.gov/actioncenter/register-apply-permits-or-request-records-0">Register, Apply for Permits, or Request Records</a>        </div>
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/identify-our-most-wanted-fugitives">Identify Our Most Wanted Fugitives</a>        </div>
              <div class="field__item odd">
          <a href="https://www.justice.gov/forms/dojform.php">Find a Form</a>        </div>
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/report-and-identify-missing-persons">Report and Identify Missing Persons</a>        </div>
              <div class="field__item odd">
          <a href="https://www.justice.gov/contact-us">Contact Us</a>        </div>
          </div>
  </div>
</div>
</div>
          </div>
</div>
<div class="panel-pane pane-fieldable-panels-pane pane-uuid-9f7f030c-af1a-4584-bdae-c9d694a23821 pane-bundle-image">
  <div class="panel-pane-inner">
                        <div class="fieldable-panels-pane" class="fieldable-panels-pane">
    <div class="field field--name-field-image-pane-image field--type-image field--label-hidden"><div class="field__items"><div class="field__item even"><a href="http://www.justice.gov/usao"><img typeof="foaf:Image" src="https://www.justice.gov/sites/default/files/image_panes/images/usao.jpg" width="268" height="95" alt="" /></a></div></div></div></div>
          </div>
</div>
  </div>
</div>
</div>
  </div>
    </div>
  
  
  
  
  
  
</div>  </div>
</div>
  </aside>
      </div>
      <!-- /.l-main -->
    </div>
    <!-- /.l-main-wrapper -->
  </div>
  <!-- /.l-lower -->

  <div class="l-footer-wrapper">
    <footer class="l-footer" role="contentinfo">
        <div class="l-region l-region--footer">
    <nav id="block-menu-menu-footer-secondary-menu" role="navigation" class="block block--menu block--menu-menu-footer-secondary-menu">
        <h2 class="block__title block__title">JUSTICE.GOV</h2>
    
  <ul class="menu"><li class="first expanded"><span class="nolink">Left Column</span><ul class="menu"><li class="first leaf"><a href="http://www.justice.gov/archive">Archive</a></li>
<li class="leaf"><a href="/accessibility/accessibility-information" title="">Accessibility</a></li>
<li class="leaf"><a href="http://get.adobe.com/reader/otherversions/" title="">Adobe Reader</a></li>
<li class="leaf"><a href="/oip" title="">FOIA</a></li>
<li class="leaf"><a href="/jmd/eeo-program-status-report" title="">No FEAR Act</a></li>
<li class="leaf"><a href="/iqpr/information-quality" title="">Information Quality</a></li>
<li class="leaf"><a href="/doj/privacy-policy" title="">Privacy Policy</a></li>
<li class="last leaf"><a href="/legalpolicies" title="">Legal Policies &amp; Disclaimers</a></li>
</ul></li>
<li class="last expanded"><span class="nolink">Right Column</span><ul class="menu"><li class="first leaf"><a href="/social" title="">Social Media</a></li>
<li class="leaf"><a href="/employees" title="">For Employees</a></li>
<li class="leaf"><a href="http://www.justice.gov/oig">Office of the Inspector General</a></li>
<li class="leaf"><a href="/open" title="">Open Government</a></li>
<li class="leaf"><a href="/open/plain-writing-act" title="">Plain Writing</a></li>
<li class="leaf"><a href="http://usa.gov">USA.gov</a></li>
<li class="last leaf"><a href="http://business.usa.gov/">BusinessUSA</a></li>
</ul></li>
</ul></nav>
<div id="block-block-2" class="block block--block block--block-2">
        <div class="block__content block__content">
    <p><img alt="DOJ" style="float:left;" src="/sites/all/themes/justice/images/us-doj-logo-text-new.png" />| 950<strong>Pennsylvania Avenue</strong>, NW Washington, DC 20530-0001</p>
  </div>
</div>
<nav id="block-menu-menu-footer-menu" role="navigation" class="block block--menu block--menu-menu-footer-menu">
        <h2 class="block__title block__title">Footer Menu</h2>
    
  <ul class="menu"><li class="first expanded"><span class="nolink">Left Column</span><ul class="menu"><li class="first expanded"><a href="/about" title="">ABOUT</a><ul class="menu"><li class="first leaf"><a href="/ag" title="">The Attorney General</a></li>
<li class="leaf"><a href="/doj/budget-and-performance" title="">Budget &amp; Performance</a></li>
<li class="leaf"><a href="/about/history" title="">History</a></li>
<li class="last leaf"><a href="/opcl" title="">Privacy Program</a></li>
</ul></li>
<li class="last expanded"><a href="/agencies/chart" title="">AGENCIES</a><ul class="menu"><li class="first leaf"><a href="/agencies/chart" title="">Organizational Chart</a></li>
<li class="last leaf"><a href="/agencies/alphabetical-listing-components-programs-initiatives" title="">Alphabetical Listing</a></li>
</ul></li>
</ul></li>
<li class="expanded"><span class="nolink">Middle Column</span><ul class="menu"><li class="first expanded"><a href="/resources" title="">RESOURCES</a><ul class="menu"><li class="first leaf"><a href="/grants" title="">Grants</a></li>
<li class="leaf"><a href="/business" title="">Business</a></li>
<li class="leaf"><a href="http://www.justice.gov/forms" title="">Forms</a></li>
<li class="leaf"><a href="/publications" title="">Publications</a></li>
<li class="last leaf"><a href="http://www.justice.gov/largecases/" title="Information for Victims in Large Cases">Information for Victims in Large Cases</a></li>
</ul></li>
<li class="last expanded"><a href="/briefing-room" title="">NEWS</a><ul class="menu"><li class="first leaf"><a href="/news" title="">Press Releases</a></li>
<li class="leaf"><a href="/public-schedule" title="">Public Schedule</a></li>
<li class="leaf"><a href="/videos" title="">Videos</a></li>
<li class="last leaf"><a href="http://www.justice.gov/opa/galleries" title="">Photos</a></li>
</ul></li>
</ul></li>
<li class="last expanded"><span class="nolink">Right Column</span><ul class="menu"><li class="first expanded"><a href="/careers" title="">CAREERS</a><ul class="menu"><li class="first leaf"><a href="/legal-careers" title="">Legal Careers</a></li>
<li class="leaf"><a href="/careers/veteran-recruitment" title="">Veteran Recruitment</a></li>
<li class="last leaf"><a href="/careers/disability-hiring" title="">Disability Hiring</a></li>
</ul></li>
<li class="last leaf"><a href="/contact-us" title="">CONTACT</a></li>
</ul></li>
</ul></nav>
  </div>
    </footer>
  </div>
</div>

  <script type="text/javascript" src="//ajax.googleapis.com/ajax/libs/jquery/1.7.2/jquery.min.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
window.jQuery||document.write("<script src='/sites/all/modules/contrib/jquery_update/replace/jquery/1.7/jquery.min.js'>\x3C/script>");
//--><!]]>
</script>
<script type="text/javascript" src="https://www.justice.gov/sites/default/files/advagg_js/js__q0X56UwREcbJyzNybeawxQuz29PS0RVFWTYH2h61iGo__djjoHl6BGDusxBd2H_7L3zvUFs7u2nVqOwQ_6Uid4Ek__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.js"></script>
<script type="text/javascript" src="//ajax.googleapis.com/ajax/libs/jqueryui/1.10.2/jquery-ui.min.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
window.jQuery.ui||document.write("<script src='/sites/all/modules/contrib/jquery_update/replace/ui/ui/minified/jquery-ui.min.js'>\x3C/script>");
//--><!]]>
</script>
<script type="text/javascript" src="https://www.justice.gov/sites/default/files/advagg_js/js__P2rLh1v2LkaimiTzQTjBZc1Vd2S--nSe5qfO4nPm4fI__7WJsicGBq887YQcKYBvGYsHw6HVr__II83PtyHK5WzA__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.js"></script>
<script type="text/javascript" src="https://www.justice.gov/sites/all/libraries/mediaelement/build/mediaelement-and-player.min.js?v=2.1.6"></script>
<script type="text/javascript" src="https://www.justice.gov/sites/default/files/advagg_js/js__HeBlbfZg31W5-k3TnSu0psp6NxEebwWqfnnTeMENJc0__0pHO0iklafpAGQz1-symT5ZS590wnV0-uwvdq3VFa80__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.js"></script>

<!--[if (gte IE 6)&(lte IE 8)]>
<script type="text/javascript" src="https://www.justice.gov/sites/default/files/advagg_js/js__UBTbecLPXcFRDNR3XjnGaFARkN87O-WXu18yLu6P1NE__YxqvutpREDoNXz22Aw7c17BIVoeHmcVG_xEpS91m3mU__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.js"></script>
<![endif]-->
<script type="text/javascript" src="https://www.justice.gov/sites/default/files/advagg_js/js__dljmKJjRlpPG5g8lmwa5Kg6T5UcOzbq5u1Pd-VLTKtk__p1ugmCg_rIauAUC_nT6m3W1TC8XqtSqXx9ZVYWisyWo__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","autocomplete_limit":{"limit":2},"colorbox":{"transition":"none","speed":"350","opacity":"0.85","slideshow":true,"slideshowAuto":true,"slideshowSpeed":"6000","slideshowStart":"start slideshow","slideshowStop":"stop slideshow","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","overlayClose":true,"returnFocus":true,"maxWidth":"98%","maxHeight":"98%","initialWidth":"300","initialHeight":"500","fixed":true,"scrolling":true,"mobiledetect":false,"mobiledevicewidth":"480px"},"nice_menus_options":{"delay":"800","speed":"fast"},"mediaelementAll":true,"better_exposed_filters":{"views":{"doj_banner":{"displays":{"block":{"filters":[]}}},"og_sidebar":{"displays":{"block_sitewide":{"filters":[]}}}}},"responsive_menus":[{"selectors":".responsive .block--nice-menus .block__content, .responsive .l-region--navigation .block__content","container":"body","trigger_txt":"\u003Cspan \/\u003E\u003Cspan \/\u003E\u003Cspan \/\u003E","close_txt":"X","close_size":"18px","position":"right","media_size":"704","show_children":"1","expand_children":"1","expand_txt":"+","contract_txt":"-","remove_attrs":"1","responsive_menus_style":"mean_menu"}],"tablesorter":{"zebra":1,"odd":"odd","even":"even"},"extlink":{"extTarget":0,"extClass":"ext","extLabel":"(link is external)","extImgClass":0,"extSubdomains":1,"extExclude":"\\.(gov|mil|fed\\.us)(\\\/.*)?$","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":"_blank","extAlertText":{"value":"The Department of Justice does not endorse the organizations or views represented by this site and takes no responsibility for, and exercises no control over, the accuracy, accessibility, copyright or trademark compliance or legality of the material contained on this site.\n\nThank you for visiting our site.","format":"full_html"},"mailtoClass":"mailto","mailtoLabel":"(link sends e-mail)"},"extlink_extra":{"extlink_alert_type":"colorbox","extlink_alert_type_colorbox_mobile":"confirm","extlink_alert_text_colorbox_mobile":"You are now leaving a Department of Justice Web site. You are about to access:\n\n[extlink:external-url]\n\nThe Department of Justice does not endorse the organizations or views represented by this site and takes no responsibility for, and exercises no control over, the accuracy, accessibility, copyright or trademark compliance or legality of the material contained on this site.\n\nThank you for visiting our site.","extlink_alert_timer":"4","extlink_alert_url":"\/now-leaving?js=1","extlink_cache_fix":1,"extlink_exclude_warning":"","extlink_508_fix":1,"extlink_508_text":" [external link]","extlink_url_override":0,"extlink_url_params":{"external_url":null,"back_url":null}},"urlIsAjaxTrusted":{"https:\/\/search.justice.gov\/search":true},"ogContext":{"groupType":"node","gid":"1664"},"ajaxPageState":{"js":{"sites\/all\/modules\/contrib\/extlink_extra\/extlink_extra.js":1,"sites\/all\/modules\/contrib\/responsive_tables_filter\/tablesaw\/js\/tablesaw.stackonly.js":1,"sites\/all\/modules\/contrib\/responsive_tables_filter\/tablesaw\/js\/tablesaw-init.js":1,"sites\/all\/libraries\/jquery.event.move\/js\/jquery.event.move.js":1,"sites\/all\/libraries\/jquery.event.swipe\/js\/jquery.event.swipe.js":1,"sites\/all\/modules\/contrib\/colorbox_swipe\/colorbox_swipe.js":1,"\/\/ajax.googleapis.com\/ajax\/libs\/jquery\/1.7.2\/jquery.min.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/no-js.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/external\/jquery.cookie.js":1,"\/\/ajax.googleapis.com\/ajax\/libs\/jqueryui\/1.10.2\/jquery-ui.min.js":1,"sites\/all\/themes\/justice\/js\/justice.early-behaviors.js":1,"sites\/all\/modules\/contrib\/nice_menus\/js\/jquery.bgiframe.js":1,"sites\/all\/libraries\/jquery.hoverIntent\/jquery.hoverIntent.js":1,"sites\/all\/modules\/contrib\/nice_menus\/js\/superfish.js":1,"sites\/all\/modules\/contrib\/nice_menus\/js\/nice_menus.js":1,"sites\/all\/libraries\/mediaelement\/build\/mediaelement-and-player.min.js":1,"misc\/form.js":1,"sites\/all\/modules\/contrib\/tablesorter\/tablesortervar.js":1,"sites\/all\/modules\/contrib\/extlink\/extlink.js":1,"sites\/all\/themes\/justice\/libraries\/html5shiv\/html5shiv.min.js":1,"sites\/all\/themes\/justice\/libraries\/html5shiv\/html5shiv-printshiv.min.js":1,"sites\/all\/themes\/justice\/libraries\/selectivizr\/selectivizr.min.js":1,"sites\/all\/libraries\/colorbox\/jquery.colorbox-min.js":1,"sites\/all\/modules\/contrib\/colorbox\/js\/colorbox.js":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.js":1,"sites\/all\/modules\/custom\/doj_analytics\/js\/doj_analytics_events.js":1,"sites\/all\/libraries\/mapify\/build\/jquery.mapify.js":1,"sites\/all\/modules\/contrib\/mediaelement\/mediaelement.js":1,"sites\/all\/modules\/features\/doj_image_map\/js\/doj_image_map_mapify.js":1,"sites\/all\/modules\/contrib\/responsive_menus\/styles\/meanMenu\/jquery.meanmenu.min.js":1,"sites\/all\/modules\/contrib\/responsive_menus\/styles\/meanMenu\/responsive_menus_mean_menu.js":1,"sites\/all\/libraries\/tablesorter\/jquery.tablesorter.min.js":1,"sites\/all\/libraries\/tablesorter\/jquery.metadata.js":1,"sites\/all\/libraries\/tablesorter\/addons\/pager\/jquery.tablesorter.pager.js":1,"misc\/collapse.js":1,"sites\/all\/modules\/features\/doj_sharing\/js\/doj_sharing.js":1,"sites\/all\/modules\/features\/doj_media\/js\/doj_media.colorbox.js":1,"sites\/all\/modules\/features\/doj_shortcode\/js\/jumpmenu.js":1,"sites\/all\/modules\/features\/doj_image_pane\/doj_image_pane.js":1,"sites\/all\/themes\/justice\/js\/justice.behaviors.js":1}}});
//--><!]]>
</script>
  <script type="text/javascript" src="https://www.justice.gov/sites/default/files/advagg_js/js__7By10u7uYYvSywdJUkrylttXj14EhgtaUf3-fDA8IhE__HBrQCUVyCkCJhNWkn6mDS0Ab3sRSYIiAVZlOlGbTrQw__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var usasearch_config={siteHandle:'justice'};
//--><!]]>
</script>
</body>
</html>
